Page last updated: 2024-11-04

sulfasalazine and Cancer of Gallbladder

sulfasalazine has been researched along with Cancer of Gallbladder in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noda, H1
Chiba, F1
Toyama, N1
Konishi, F1
STAUFFER, MH1
SAUER, WG1
DEARING, WH1
BAGGENSTOSS, AH1

Other Studies

2 other studies available for sulfasalazine and Cancer of Gallbladder

ArticleYear
Mucin-producing carcinoma of the gallbladder associated with primary sclerosing cholangitis and ulcerative colitis.
    Journal of hepato-biliary-pancreatic surgery, 2009, Volume: 16, Issue:1

    Topics: Adenocarcinoma, Mucinous; Aged; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Re

2009
THE SPECTRUM OF CHOLESTATIC HEPATIC DISEASE.
    JAMA, 1965, Mar-08, Volume: 191

    Topics: Adolescent; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Duct Neoplasms; Bilirubin; Blood

1965